Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer

BAP1 is an emerging tumor suppressor whose inactivating mutations have been found to play critical roles in tumor development. This study was conducted to elucidate the potential value of BAP1 mutation in guiding prognostic prediction and clinical stratification. We conducted a comprehensive analysi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiang-Yu Wang, Zheng Wang, Jian-Bo Huang, Xu-Dong Ren, Dan Ye, Wen-Wei Zhu, Lun-Xiu Qin
Format: Article
Language:English
Published: SAGE Publishing 2017-05-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317699111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248839618265088
author Xiang-Yu Wang
Zheng Wang
Jian-Bo Huang
Xu-Dong Ren
Dan Ye
Wen-Wei Zhu
Lun-Xiu Qin
author_facet Xiang-Yu Wang
Zheng Wang
Jian-Bo Huang
Xu-Dong Ren
Dan Ye
Wen-Wei Zhu
Lun-Xiu Qin
author_sort Xiang-Yu Wang
collection DOAJ
description BAP1 is an emerging tumor suppressor whose inactivating mutations have been found to play critical roles in tumor development. This study was conducted to elucidate the potential value of BAP1 mutation in guiding prognostic prediction and clinical stratification. We conducted a comprehensive analysis of relevant studies from multiple databases, to determine the impact of BAP1 mutation on the overall survival and disease-free survival of patients in various cancers. A total of 2457 patients from 21 studies were included in the final analysis. Although the pooled results demonstrated that BAP1 mutation was a negative indicator of overall survival (hazard ratio = 1.73; 95% confidence interval = 1.23–2.42) and disease-free survival (hazard ratio = 2.25; 95% confidence interval = 1.47–3.45), this prognostic value was only applicable to uveal melanoma and clear cell renal cell carcinoma, but not to malignant pleural mesothelioma or cholangiocarcinoma. Consistently, BAP1 mutation was correlated with critical clinicopathological features only in uveal melanoma and clear cell renal cell carcinoma. In uveal melanoma, BAP1 mutation and SF3B1/EIF1AX mutations were negatively correlated, and BAP1-mutant tumors indicated significant worse prognosis than SF3B1/EIF1AX-mutant tumors ( p  = 0.028). While in clear cell renal cell carcinoma, BAP1 mutation was mutually exclusive with PBRM1 mutations, and BAP1-mutant clear cell renal cell carcinomas also showed significantly worse prognosis than PBRM1-mutant clear cell renal cell carcinomas ( p  = 0.001). Our study revealed a unique tissue-specific significance of BAP1 mutation in prognostic prediction among different types of cancer. Clinically, combining detection of BAP1 mutation and other driver mutations may further allow for a more precise molecular taxonomy to stratify patients into distinct subgroups in uveal melanoma and clear cell renal cell carcinoma.
format Article
id doaj-art-bb1d3e988f7e412bb5abed455b9e42e2
institution Kabale University
issn 1423-0380
language English
publishDate 2017-05-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-bb1d3e988f7e412bb5abed455b9e42e22025-08-20T03:57:44ZengSAGE PublishingTumor Biology1423-03802017-05-013910.1177/1010428317699111Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancerXiang-Yu Wang0Zheng Wang1Jian-Bo Huang2Xu-Dong Ren3Dan Ye4Wen-Wei Zhu5Lun-Xiu Qin6Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaMolecular and Cell Biology Lab, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai, ChinaBAP1 is an emerging tumor suppressor whose inactivating mutations have been found to play critical roles in tumor development. This study was conducted to elucidate the potential value of BAP1 mutation in guiding prognostic prediction and clinical stratification. We conducted a comprehensive analysis of relevant studies from multiple databases, to determine the impact of BAP1 mutation on the overall survival and disease-free survival of patients in various cancers. A total of 2457 patients from 21 studies were included in the final analysis. Although the pooled results demonstrated that BAP1 mutation was a negative indicator of overall survival (hazard ratio = 1.73; 95% confidence interval = 1.23–2.42) and disease-free survival (hazard ratio = 2.25; 95% confidence interval = 1.47–3.45), this prognostic value was only applicable to uveal melanoma and clear cell renal cell carcinoma, but not to malignant pleural mesothelioma or cholangiocarcinoma. Consistently, BAP1 mutation was correlated with critical clinicopathological features only in uveal melanoma and clear cell renal cell carcinoma. In uveal melanoma, BAP1 mutation and SF3B1/EIF1AX mutations were negatively correlated, and BAP1-mutant tumors indicated significant worse prognosis than SF3B1/EIF1AX-mutant tumors ( p  = 0.028). While in clear cell renal cell carcinoma, BAP1 mutation was mutually exclusive with PBRM1 mutations, and BAP1-mutant clear cell renal cell carcinomas also showed significantly worse prognosis than PBRM1-mutant clear cell renal cell carcinomas ( p  = 0.001). Our study revealed a unique tissue-specific significance of BAP1 mutation in prognostic prediction among different types of cancer. Clinically, combining detection of BAP1 mutation and other driver mutations may further allow for a more precise molecular taxonomy to stratify patients into distinct subgroups in uveal melanoma and clear cell renal cell carcinoma.https://doi.org/10.1177/1010428317699111
spellingShingle Xiang-Yu Wang
Zheng Wang
Jian-Bo Huang
Xu-Dong Ren
Dan Ye
Wen-Wei Zhu
Lun-Xiu Qin
Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
Tumor Biology
title Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
title_full Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
title_fullStr Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
title_full_unstemmed Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
title_short Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
title_sort tissue specific significance of bap1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
url https://doi.org/10.1177/1010428317699111
work_keys_str_mv AT xiangyuwang tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT zhengwang tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT jianbohuang tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT xudongren tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT danye tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT wenweizhu tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer
AT lunxiuqin tissuespecificsignificanceofbap1genemutationinprognosticpredictionandmoleculartaxonomyamongdifferenttypesofcancer